AKT1 and neoplasm: In contrast, Jiang et al reported that bufalin inhibited the phosphorylation of Akt, NF-κB, p44/42 MAPK (ERK1/2), and p38 MAPK in A549 cells (42) suggesting MAP kinase could be differentially regulated by bufalin depending on tumor cell types.